Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR

Clinical trial NCT00532701 · COMPLETED

Trial details

NCT number: NCT00532701
Sponsor: National Taiwan University Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2007-11-01
Primary completion: 2014-03-01
Enrollment: 880

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.